Comparative Pharmacokinetics of Vitamin K Antagonists
- 1 January 2005
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 44 (12) , 1227-1246
- https://doi.org/10.2165/00003088-200544120-00003
Abstract
Vitamin K antagonists belong to the group of most frequently used drugs worldwide. They are used for long-term anticoagulation therapy, and exhibit their anticoagulant effect by inhibition of vitamin...Keywords
This publication has 162 references indexed in Scilit:
- Comparison of Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism after Total Knee ReplacementNew England Journal of Medicine, 2003
- Ximelagatran versus warfarin forstroke prevention in patientswith nonvalvular atrial fibrillation: SPORTIF ii: a dose-guiding, tolerability, and safety studyJournal of the American College of Cardiology, 2003
- Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish PopulationBiochemical and Biophysical Research Communications, 1999
- Clinically Important Drug Interactions with AnticoagulantsClinical Pharmacokinetics, 1996
- Clinically Significant Drug Interactions with the Oral AnticoagulantsDrug Safety, 1994
- Interaction of phenylbutazone with racemic phenprocoumon and its enantiomers in ratsJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Clinical Pharmacokinetics of Oral AnticoagulantsClinical Pharmacokinetics, 1979
- A new warfarin metabolite: structure and functionJournal of Medicinal Chemistry, 1978
- Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in manJournal of Pharmacy and Pharmacology, 1973
- The plasma half lives and the pharmacological effect of the enantiomers of warfarin in ratsLife Sciences, 1972